Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.

Next Previous
Trial Profile

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use

Most Recent Events

  • 12 Aug 2019 Planned End Date changed from 1 Jul 2013 to 31 Dec 2010.
  • 12 Aug 2019 Planned primary completion date changed from 1 Jun 2013 to 31 Dec 2010.
  • 20 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top